A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age
Clinical trial NCT07478952 · RECRUITING
Trial details
- NCT number
- NCT07478952
- Sponsor
- ModernaTX, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-17
- Primary completion
- 2027-05-15
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.